Pubmed ID: 31409596

Pubmed Central ID: PMC6777587

Journal: Clinical journal of the American Society of Nephrology : CJASN

Publication Date: Oct. 7, 2019

Affiliation: Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Link: https://cjasn.asnjournals.org/content/clinjasn/early/2019/08/12/CJN.00370119.full.pdf?link_time=2024-04-20_07:11:22.240389

MeSH Terms: Humans, Male, Female, Aged, Middle Aged, Kidney Diseases, Diabetes Mellitus, Type 2, Hypolipidemic Agents, Kidney Tubules, Biomarkers, Fenofibrate

Grants: U01 DK106962, R01 DK096549, UL1 TR001863

Authors: Coca SG, Parikh CR, Garg AX, Chan L, Nadkarni GN, Chauhan K, Debnath N, Saha A

Cite As: Chauhan K, Nadkarni GN, Debnath N, Chan L, Saha A, Garg AX, Parikh CR, Coca SG. The Association of Fenofibrate with Kidney Tubular Injury in a Subgroup of Participants in the ACCORD Trial. Clin J Am Soc Nephrol 2019 Oct 7;14(10):1521-1523. Epub 2019 Aug 13.

Studies:

• Action to Control Cardiovascular Risk in Diabetes (ACCORD)